What is Favipiravir? FDA Approves COVID Prevention Study in US Nursing Homes
Armand Balboni, MD, PhD, discusses progress toward FDA authorization and/or approval of favipiravir for COVID-19 as a prophylactic measure.
Related Articles
Study Reveals Transmission of Candida auris from Adults to Children in Maryland Hospital
The results were presented at the Society for Healthcare Epidemiology of America (SHEA) conference, highlighting this first documented case of C auris moving from an…
GSK 5-in-1 Meningococcal Vaccine Given a PDUFA
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Clostridioides Difficile Infection Testing Patterns and Outcomes Following Laxative Administration
A study, presented at the Society for Healthcare Epidemiology of America (SHEA) conference, assesses laxative administration before CDI testing in Veteran Affairs (VA) hospitals and…
AI in HAI Prevention: A Sustainable Approach
Hospitals grapple with the costly burden of healthcare-associated infections (HAIs), and artificial intelligence (AI) is emerging as a game-changer in revolutionizing infection prevention strategies.
More Than Half of Severe COVID-19 Inpatients Have Persistent Health Issues Post Hospitalization
A small study found physical health problems lingered 1 year after their hospital stay.
GSK 5-in-1 Meningococcal Vaccine Given a PDUFA
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
New Data on the Impact of Hepatitis and the Path to Elimination
Current progress of WHO’s strategies to enhance global health outcomes through improved diagnosis and treatment of viral hepatitis.
More Than Half of Severe COVID-19 Inpatients Have Persistent Health Issues Post Hospitalization
A small study found physical health problems lingered 1 year after their hospital stay.
Nationwide Listeria Outbreak Linked to Cheese is Officially Closed
Officials announce an end of Listeria traced to Rizo-López dairy products involving queso fresco and cotija.
CDC Strategies Tested for Preventing Hospital-Onset C difficile
Incidence of hospital-onset Clostridioides difficile infection differed between hospitals that implemented the CDC prevention strategies and those that did not, but not necessarily because of…